Range
- - -
Vol / Avg.
0.1K/3.5M
Div / Yield
-
52 Wk
1.27 - 3.89
Mkt Cap
38.9M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.04
Shares
23.9M
Outstanding
23.9M
Total Float
23M
Benzinga - 6 days ago
Benzinga - Jun 7, 2021, 2:37PM
Benzinga - Jun 7, 2021, 2:33PM
Benzinga - Jun 3, 2021, 12:32PM
Benzinga - Jun 3, 2021, 8:06AM
Benzinga - May 21, 2021, 12:03PM
Benzinga - May 18, 2021, 10:41AM
Benzinga - May 13, 2021, 8:30AM
Benzinga - May 7, 2021, 8:18AM
Benzinga - May 5, 2021, 9:24AM
Benzinga - May 3, 2021, 9:14AM
Benzinga - Apr 22, 2021, 9:03AM
Benzinga - Apr 20, 2021, 2:07PM
Benzinga - Apr 20, 2021, 9:28AM
Benzinga - Apr 20, 2021, 9:15AM
Benzinga - Apr 15, 2021, 8:37AM
Benzinga - Apr 15, 2021, 8:36AM
Benzinga - Apr 13, 2021, 8:07AM
Benzinga - Apr 12, 2021, 9:20AM
Benzinga - Apr 6, 2021, 9:16AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-12
REV
Q1 2021Est.ActualSurprise
EPS-0.240
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HOTHHoth Therapeutics-1.84%38.9M

Hoth Therapeutics Frequently Asked Questions

Q

How do I buy Hoth Therapeutics (HOTH) stock?

A

You can purchase shares of Hoth Therapeutics (NASDAQ: HOTH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Hoth Therapeutics's (HOTH) competitors?

A

Other companies in Hoth Therapeutics’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Teligent (NASDAQ:TLGT), Pulmatrix (NASDAQ:PULM), Cumberland (NASDAQ:CPIX) and Titan Pharmaceuticals (NASDAQ:TTNP).

Q

What is the target price for Hoth Therapeutics (HOTH) stock?

A

The latest price target for Hoth Therapeutics (NASDAQ: HOTH) was reported by Benchmark on October 15, 2019. The analyst firm set a price target for 10.00 expecting HOTH to rise to within 12 months (a possible 513.50% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Hoth Therapeutics (HOTH)?

A

The stock price for Hoth Therapeutics (NASDAQ: HOTH) is $1.63 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Hoth Therapeutics (HOTH) pay a dividend?

A

There are no upcoming dividends for Hoth Therapeutics.

Q

When is Hoth Therapeutics (NASDAQ:HOTH) reporting earnings?

A
Hoth Therapeutics’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Hoth Therapeutics (HOTH) going to split?

A

There is no upcoming split for Hoth Therapeutics.

Q

What sector and industry does Hoth Therapeutics (HOTH) operate in?

A

Hoth Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.